The intra-islet role of the delta-cells and the impact of dysregulated somatostatin secretion on the defective counter-regulatory alpha-cell glucagon response to hypoglycaemia in T1D are excellent examples of a potentially novel tool in diabetes control. This evidence concerns the gene GCG and type 1 diabetes mellitus.